The clinicopathological significance of bmi-1 expression in pathogenesis and progression of gastric carcinomas

Asian Pacific Journal of Cancer Prevention

Volumn 13, Issue 7, 2012, Pages 3437-3441

  Lu, Hang ^a   Sun, Hong Zhi ^a   Li, Hua ^a   Cong, Ming ^a  

^a JINZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Bmi 1; Gastric carcinoma; Pathogenesis; Prognosis; Progression

Indexed keywords

EID: 84873591100     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2012.13.7.3437     Document Type: Article

References (31)

1. Engelsen IB, Mannelqvist M, Stefansson IM, et al(2008). Low BMI-1 expression is associated with an activated BMI-1-driven signature, vascular invasion, and hormone receptor loss in endometrial carcinoma. Br J Cancer, 98, 1662-9.
2. Grinstein E, Mahotka C. Stem cell divisions controlled by the proto-oncogene BMI-1. J Stem Cells, 4, 141-6.
3. Guo BH, Feng Y, Zhang R, et al(2010). Bmi-1 promotes invasion and metastasis, and its elevated expression is correlated with an advanced stage of breast cancer. Mol Cancer, 10, 10.
4. Häyry V, Mäkinen LK, Atula T, et al(2010). Bmi-1 expression predicts prognosis in squamous cell carcinoma of the tongue. Br J Cancer, 102, 892-7.
5. Honig A, Weidler C, Häusler S, et al(2010). Overexpression of polycomb protein BMI-1 in human specimens of breast, ovarian, endometrial and cervical cancer. Anticancer Res, 30, 1559-64.
6. Huang J, Qiu Y, Chen G, Huang L, He J (2011). The relationship between Bmi-1 and the epithelial-mesenchymal transition in lung squamous cell carcinoma. Med Oncol, [Epub ahead of print] PubMed
7. Huber GF, Albinger-Hegyi A, Soltermann A, et al(2010). Expression patterns of Bmi-1 and p16 significantly correlate with overall, disease-specific, and recurrence-free survival in oropharyngeal squamous cell carcinoma. Cancer in press.
8. Itahana K, Zou Y, Itahana Y, et al(2003). Control of the replicative life span of human fibroblasts by p16 and the polycomb protein Bmi-1. Mol Cell Biol, 23, 389-401.
9. Jiang L, Li J, Song L (2009). Bmi-1, stem cells and cancer. Acta Biochim Biophys Sin (Shanghai), 41, 527-34.
10. Kozakowski N, Soleiman A, Pammer J (2008). BMI-1 expression is inversely correlated with the grading of renal clear cell carcinoma. Pathol Oncol Res, 14, 9-13.
11. Li DW, Tang HM, Fan JW, et al(2010). Expression level of Bmi-1 oncoprotein is associated with progression and prognosis in colon cancer. J Cancer Res Clin Oncol, 136, 997-1006.
12. Li W, Li Y, Tan Y, Ma K, Cui J(2010). Bmi-1 is critical for the proliferation and invasiveness of gastric carcinoma cells. J Gastroenterol Hepatol, 25, 568-75.
13. Liu WL, Guo XZ, Zhang LJ, et al(2010). Prognostic relevance of Bmi-1 expression and autoantibodies in esophageal squamous cell carcinoma. BMC Cancer, 10, 467.
14. Milyavsky M, Shats I, Erez N, et al(2009). Prolonged culture of telomerase-immortalized human fibroblasts leads to a premalignant phenotype. Cancer Res, 63, 7147-57.
15. Min L, Dong-Xiang S, Xiao-Tong G, Ting G, Xiao-Dong C (2011). Clinicopathological and prognostic significance of Bmi-1 expression in human cervical cancer. Acta Obstet Gynecol Scand, 90, 737-45.
16. Qin ZK, Yang JA, Ye YL, et al(2010). Expression of Bmi-1 is a prognostic marker in bladder cancer. BMC Cancer, 9, 61.
17. Song LB, Li J, Liao WT, et al(2009).The polycomb group protein Bmi-1 represses the tumor suppressor PTEN and induces epithelial-mesenchymal transition in human nasopharyngeal epithelial cells. J Clin Invest, 119, 3626-36.
18. Song W, Tao K, Li H et al(2010). Bmi-1 is related to proliferation, survival and poor prognosis in pancreatic cancer. Cancer Sci, 101, 1754-60.
19. Wang JF, Liu Y, Liu WJ, He SY (2010). Expression of Bmi-1 gene in esophageal carcinoma cell EC9706 and its effect on cell cycle, apoptosis and migration. Chin J Cancer, 29, 689-96.
20. Wang Y, Zhe H, Ding Z, et al(2012). Cancer stem cell marker Bmi-1 expression is associated with basal-like phenotype and poor survival in breast cancer. World J Surg, 36, 1189-94.
21. Xiao J, Deng C(2009). Knockdown of Bmi-1 impairs growth and invasiveness of human gastric carcinoma cells. Oncol Res, 17, 613-20.
22. Xu Z, Liu H, Lv X, et al(2011). Knockdown of the Bmi-1 oncogene inhibits cell proliferation and induces cell apoptosis and is involved in the decrease of Akt phosphorylation in the human breast carcinoma cell line MCF-7. Oncol Rep, 25, 409-18.
23. Yang GF, He WP, Cai MY, et al(2010). Intensive expression of Bmi-1 is a new independent predictor of poor outcome in patients with ovarian carcinoma. BMC Cancer, 10, 133.
24. Yin T, Wei H, Leng Z, et al(2011). Bmi-1 promotes the chemoresistance, invasion and tumorigenesis of pancreatic cancer cells. Chemotherapy, 57, 488-96.
25. Yu M, Zheng HC, Xia P, et al(2010). Comparison in pathological behaviours & prognosis of gastric cancers from general hospitals between China & Japan. Indian J Med Res, 132, 295-302.
26. Zhang X, Wang C, Wang L, et al(2012). Detection of circulating Bmi-1 mRNA in plasma and its potential diagnostic and prognostic value for uterine cervical cancer. Int J Cancer, 131, 165-72.
27. Zhang X, Wang CX, Zhu CB, et al(2010). Overexpression of Bmi-1 in uterine cervical cancer: correlation with clinicopathology and prognosis. Int J Gynecol Cancer, 20, 1597-603.
28. Zhang YC (1994). Geographic pathology of gastric dysplasia in China. Semin Surg Oncol, 10, 100-6.
29. Zheng H, Takahashi H, Murai Y, et al(2007). Pathobiological characteristics of intestinal and diffuse-type gastric carcinoma in Japan: an immunostaining study on the tissue microarray. J Clin Pathol, 60, 273-7.
30. Zheng HC, Li XH, Hara T, et al(2008). Mixed-type gastric carcinomas exhibit more aggressive features and indicate the histogenesis of carcinomas. Virchows Arch, 452, 525-34.
31. Zheng HC, Xu XY, Yu M, et al(2010). The role of Reg IV gene and its encoding product in gastric carcinogenesis. Hum Pathol, 41, 59-69.